Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Mur P; Pozuelo A; Tabernero J; Albanell J; Bellosillo B; Bosch F; Briones J; Brunet J; Colomer D; Domènech M; Fontanet JM; Matias-Guiu X; Salazar R; Vivanco-Hidalgo RM; Mollà M; Moreno L; Prat A; Ribera JM; Clèries R; Guarga A; Piñol JAE; Borras JM
Response to the letter to the editor entitled "The precision of a report on precision".
Clinical & Translational Oncology 28 1076-1078. .
-
Vidal-Sabanés, M; Bonifaci, N; Navaridas, R; Egea, J; Encinas, M; Rodriguez-Barrueco, R; Silva, JM; Matias-Guiu, X; Tarragona, J; Llobet-Navas, D; Dolcet, X
miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency
Cell Death & Disease 17 -. .
-
Vidal-Sabanés, M; Navaridas, R; Bonifaci, N; Gay-Rua, A; Ortega-Peinado, D; Egea, J; Encinas, M; Matias-Guiu, X; Llobet-Navas, D; Dolcet, X
Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma
Cancer Communications 46 -. .
-
González-Martínez, S; Palacios, J; Carretero-Barrio, I; Fernández-Lanza, V; Cortés-Salgado, A; Román, J; Matias-Guiu, X; Gatius, S; Cortés, J; Pérez-Mies, B
Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification
JOURNAL OF PATHOLOGY 268 227-242. .
-
Agaimy, A; Chiang, SR; Michal, M; Dermawan, JK; Clarke, BA; Emons, J; Stoehr, R; Beckmann, MW; Hartmann, A; Hodgson, A; Matias-Guiu, X; Antonescu, CR; Dickson, BC
ESR1::NCOA2/3 fusions in uterine neoplasms with adenosarcoma-like morphology: clinicopathologic and molecular features of 12 cases and review of the literature
VIRCHOWS ARCHIV -. .
-
Kasius, JC; Kildal, W; Vrede, SW; Askautrud, HA; Pradhan, M; Van Altena, AM; Tobin, KAR; Knoll, K; Reijnen, C; Reimann, S; Dackus, G; Vlatkovic, L; Huvila, J; Steinlechner, M; Tubita, V; Gil-Moreno, A; Snijders, MPLM; Vos, MC; Hveem, TS; Asberger, J; Zeimet, AG; Matias-Guiu, X; Lindemann, K; Weinberger, V; Visser, NCM; Kristensen, GB; Amant, F; Pijnenborg, JMA; Kleppe, A
Surgical stage in the era of molecular profiling of endometrial cancer
EUROPEAN JOURNAL OF CANCER 233 116164-116164. .
-
Lombaers, MS; Reijnen, C; Sprik, A; Bretová, P; Grube, M; Vrede, S; Berg, HF; Asberger, J; Colas, E; Hausnerova, J; Huvila, J; Gil-Moreno, A; Matias-Guiu, X; Simons, M; Snijders, MPLM; Visser, NCM; Kommoss, S; Weinberger, V; Amant, F; Bronsert, P; Haldorsen, IS; Koskas, M; Krakstad, C; Küsters-Vandevelde, HVN; Mancebo, G; van der Putten, LJM; de la Calle, I; Lucas, PJF; Hommersom, A; Pijnenborg, JMA
ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
EUROPEAN JOURNAL OF CANCER 231 116058-116058. .
-
Bosse, T; Nout, R; Matias-Guiu, X; Concin, N
It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer
LANCET ONCOLOGY 26 573-573. .
-
Asaturova, A; Pinto, J; Polonia, A; Karpulevich, E; Mattias-Guiu, X; Eloy, C
Artificial Intelligence Tools for Supporting Histopathologic and Molecular Characterization of Gynecological Cancers: A Review
Journal of Clinical Medicine 14 -. .
-
Vidal-Sabanés, M; Bonifaci, N; Navaridas, R; Egea, J; Encinas, M; Rodriguez-Barrueco, R; Silva, JM; Matias-Guiu, X; Llobet-Navas, D; Dolcet, X
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503
Cell Death & Disease 16 705-705. .
-
Tresserra, F; Colmenero, I; Iglesias, M; Ortega, L; Temprana-Salvador, J; Lorente, AM; Dinares, C; Mayordomo, E; Lozano, MD; Guiu, XM; Cajal, SRY
Management of second opinions in pathology: Recommendations of the Spanish Society of Anatomical Pathology (SEAP). Second opinions in pathology
Revista Espanola de Patologia 58 100837-100837. .
-
Kostun, J; Nowosielski, K; Jedryka, MA; Hardisson, D; Restaino, S; Gatius, S; Novak, Z; Lacalle, AS; Lopez, S; Pesta, M; Zebalski, M; Lepka, P; Diestro, MD; Vizzielli, G; Matias-Guiu, X; Echim, T; Urkaray, ENC; Rienda, I; Slunecko, R; Czekanski, A; Berjón, A; Mariuzzi, L; Velasco, A; Betenbuk, J; Merino, IG; Padilla-Iserte, P; Stránik, P; Smoligová, V; Presl, J
One-Step Nucleic Acid Amplification Analysis of Sentinel Lymphatic Nodes in Endometrial Cancer Patients (EU-OSNA): A European Multicenter Diagnostic Accuracy Study
Cancer Medicine 14 -. .
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
